Applied Therapeutics
APLT
APLT was delisted on the 2nd of February, 2026.
89 hedge funds and large institutions have $639M invested in Applied Therapeutics in 2024 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 34 increasing their positions, 17 reducing their positions, and 24 closing their positions.
2,571% more call options, than puts
Call options by funds: $45.8M | Put options by funds: $1.71M
210% more capital invested
Capital invested by funds: $206M → $639M (+$433M)
100% more funds holding in top 10
Funds holding in top 10: 3 → 6 (+3)
100% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 17
25% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 24
9.17% more ownership
Funds ownership: 79.57% → 88.74% (+9.2%)
7% more funds holding
Funds holding: 83 → 89 (+6)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
|
+$19.2M |
| 2 |
PA
Perceptive Advisors
New York
|
+$17.6M |
| 3 |
Franklin Resources
San Mateo,
California
|
+$15.9M |
| 4 |
Morgan Stanley
New York
|
+$14.1M |
| 5 |
VA
VR Adviser
New York
|
+$12.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$8.13M |
| 2 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$5.56M |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
-$5.22M |
| 4 |
Renaissance Technologies
New York
|
-$2.14M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.59M |
APLT Hedge Fund Activity: Q1 2024 in Review
89 of the 6,959 institutional investors tracked by Wall St. Rank reported a position in Applied Therapeutics (APLT) for Q1 2024, worth a combined $639M — up 210% from $206M a quarter earlier.
Buyers outnumbered sellers: 30 funds opened new APLT positions and 24 closed out — a net gain of 6 holders — while 34 added to existing stakes and 17 trimmed.
The largest buyer was Janus Henderson Group, adding an estimated $19.2M. The largest seller was Fidelity Investments, exiting entirely with an estimated $8.13M sold.
- 89 institutional investors held Applied Therapeutics (APLT) as of Q1 2024, up from 83 in Q4 2023.
- Funds reported $639M of Applied Therapeutics stock for Q1 2024, up 210% quarter-over-quarter.
- 30 funds opened new Applied Therapeutics positions in Q1 2024 and 24 closed out, a net change of +6 holders.
- The largest Applied Therapeutics buyer in Q1 2024 was Janus Henderson Group, an estimated $19.2M added.
- The largest Applied Therapeutics seller in Q1 2024 was Fidelity Investments, an estimated $8.13M sold.
Based on aggregated 13F filings for Q1 2024.